You are not logged in.

#1 2020-09-12 21:03:13

From: United States, South Boston
Registered: 2020-09-12
Posts: 1

BioView’s Lung Cancer Early Diagnostic Research

Godlan migrated to Dynamic Quest
Posted on Saturday September 12, 2020

Case Study: Managed Partner Hosting The Situation. Godlan, Inc. is an ERP reseller, serving clients in the manufacturing sector. The company was dissatisfied with its hosting vendor, a well-known commodity provider. They wanted a better solution that provided their clients with a more stable and cost effective hosted- environment . Here’s what they discovered. It’s not […]

The post Godlan migrated to Dynamic Quest appeared first on M88bet.

Duel Devastator Single Cards – Duel Kingdom
Posted on Saturday September 12, 2020

/ Collection Duel Devastator Single Cards Filter No filter 1st Edition Aqua Continuous Spell Continuous Trap Counter Trap Cyberse Dark. Thunder Trap Tuner/ Effect Monster Ultra Rare Water Wind Winged Beast Wyrm Xyz/Effect Monster. D. Crow [DUDE-EN027 Ultra Rare] $1.00 D. D. Crow [DUDE-EN027 Ultra Rare] Add 1x Near Mint 1st Edition ($1.00 ) to […]

The post Duel Devastator Single Cards – Duel Kingdom appeared first on M88bet.

Called by the Grave [DUDE-EN044 Ultra Rare]
Posted on Saturday September 12, 2020

/ Yugioh Single Called by the Grave [DUDE-EN044] Ultra Rare translation missing: en.general.social.alt_text.share_on_facebook translation missing: en.general.social.alt_text.share_on_twitter Called by the Grave [DUDE-EN044 Ultra Rare] . Out Of Stock!. We will notify you when this product becomes available. Available on: Regular price 13 in stock   – + Near Mint 1st Edition – Lightly Played 1st Edition […]

The post Called by the Grave [DUDE-EN044 Ultra Rare] appeared first on M88bet.

IBM iSeries PDF Spool File Archive
Posted on Saturday September 12, 2020

IBM iSeries PDF Spool File Archive . Menu IBM iSeries PDF Spool File Archive. ARCHIVE iSeries Pap erless PDF Spool File Archive An easy way to transform all your IBM iSeries Spool Files into a FULL TEXT SEARCHABLE Archive of PDF viewable reports accessible Anywhere Anytime via a Graphical Web Browser . Download ProntoARCHIVE iSeries Flyer […]

The post IBM iSeries PDF Spool File Archive appeared first on M88bet.

Mad Catz MLG Pro Circuit Controller review & comparison
Posted on Saturday September 12, 2020

Mad Catz MLG Pro Circuit Controller review & comparison. January 20th, 2012 Wherein the author reviews the newly released Mad Catz MLG Pro Circuit Controller and compares it to the OEM Microsoft Xbox Controller and the Razer Onza. The Playstation DUALSHOCK3 is also featured briefly. In August of last year, Mad Catz announced a series […]

The post Mad Catz MLG Pro Circuit Controller review & comparison appeared first on M88bet.

Fedora Fedora 32 vs Fedora 31 – Comparison Table
Posted on Tuesday September 08, 2020

Fedora . Fedora 32 vs Fedora 31 – Comparison Table How To. Linux Tutorials. Operating-Sytems. Fedora 32 vs Fedora 31 – Comparison Table . By Kibet John – May 2 2020 1750 0 Share Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Tumblr Telegram Mix VK Digg. Download the guide as PDF Close With the release […]

The post Fedora Fedora 32 vs Fedora 31 – Comparison Table appeared first on M88bet.

For Beginners Articles for Beginners
Posted on Tuesday September 08, 2020

Home. Articles Business. Personal success. Technology. Health, Wellness, & Motivation. Reviews Editors’ Choice. Books. Business. Educational. Games. Music. Technology. Upcoming. Websites. Archived. Videos Videos for beginners . For Business. Motivational. For Your Success . News CES Coverage . Cool News. For Beginners Articles for Beginners. Videos for Beginners . Safe Shopping. About us Who we […]

The post For Beginners Articles for Beginners appeared first on M88bet.

Understanding the Freelance Market
Posted on Tuesday September 08, 2020

Understanding the Freelance Market . May 29, 2019May 18. 2020 1190 Views 0 Comment America Andrews, business2community, Edelman, freecodecamp, freelance, Freelancers, Intelligence, interview, Java, jobs, Market, Peter, Roger, Studner, Understanding By Roger Andrews Looking for a job can be unnerving. The anxiety of looking for jobs, going through interview s, and following up on results – is […]

The post Understanding the Freelance Market appeared first on M88bet.

>  > Company Profile.
Company Profile.
About Us.
BioView develops, manufactures and markets innovative automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories.
Operating since 2000.

BioView is headquartered in Israel and has a fully owned subsidiary in the Unites States

which is responsible for sales and support in America.

Products are also an internationally distributed by Abbott Molecular

Founded and managed by experts, BioView leverages its knowledge and extensive expertise in the areas of medical devices combined with clinical and research applications, in creating its breakthrough imaging and analysis solutions.
Lead by senior executives with vast accumulated experience in both the development and successful marketing of solutions such as diagnostic equipment with vision applications, BioView remains one step ahead of the game with assay-specific applications ready for use even before the tests reach the market.
Technological Excellence.
BioView’s proprietary imaging, analysis and review technology automatically controls fully motorized fluorescent and bright-field microscopes equipped with high resolution cameras.
This automates the review, analysis and reporting processes and reduces laboratories’ turn-around time on labor intensive tests.
BioView’s scanning equipment and imaging & analysis algorithms have been tested and validated by world leading institutes, and have been proven to meet the requirements of both research and clinical laboratories.
Its commitment to always meet market trends, support new and emerging tests, and implement the most advanced imaging and optical solutions, while optimizing workflows, .

Reinforces BioView’s position as an industry leader

BioView’s Noninvasive, Early Detection Lung Cancer Test.
The company is currently developing and plans to market its proprietary, self-developed test for noninvasive early detection of lung cancer, .

Combining a biological test kit and BioView’s unique Target FISH application

Download Presentation Lung Cancer Early Diagnostic – Project Description  Background : Lung cancer is the leading cause of cancer deaths worldwide with a continuously increasing incidence.
Despite decades of research, prognosis is still poor – lung cancer patients have 85% chance of death within 5 years.
For many patients, successful treatment remains elusive as advanced tumors are often inoperable and may also be resistant to tolerable doses of radiotherapy and chemotherapy.
On the other hand, individuals with early stage disease are often cured through surgical resection.
This dichotomy in outcome has resulted in a growing effort to design and test new methods for early detection of lung cancer.
Documented genetic abnormalities associated with initiation and progression of lung cancer includes point mutations, allelic loss and methylation of tumor suppressor genes.
However, to date, none of these abnormalities have proven successful as biomarkers for early detection or in predicting who will get lung cancer and who might benefit from early intervention.
Obstacles to the clinical application of these molecular lesions as biomarkers are many.
They include the heterogeneity of lung tumors, infrequency of individual markers in the lung cancer population, remoteness from imminent malignant transformation and the lack of expression in accessible specimens such as sputum.
Sputum cytology plays a limited role in lung cancer screening studies as it has a low yield in detecting lung cancer due to the peripheral nature of many lung cancers, which are mostly adenocarcinomas.
However, because sputum collection is a non-invasive test, the development of robust biomarkers that could be tested on cells in sputum that are indicative of the presence of cancer or an increased risk to develop lung cancer, would be highly beneficial.
BioView’s Lung Cancer Early Diagnostic Research.
BioView has acquired the exclusive rights to continue the development and to commercialize a set of FISH (Fluorescent In-Situ Hybridization) genetic probes that were discovered by a leading research group at MD Anderson Cancer Center.
The initial research on these FISH probes done at MD Anderson showed that they have a high sensitivity for deletions in early-stage non-small-cell lung cancer when used on specimens taken from bronchial washings Our DUET™ system for scanning in Bright-Field and fluorescent modes allows the same slide to be scanned twice with two different markers: Morphology marker and FISH biomarker.
The coordinates and images of all cells found in the first scan are saved and matched to the fluorescent images of the second scan.
Using this technology, the cells are initially classified by their morphology and then analyzed for their FISH pattern.
This novel and unique Target-FISH technique has been previously used to improve the sensitivity and specificity of FISH results.
We have successfully applied this technique for multiple myeloma follow-up, other hematology diseases and for bladder cancer recurrence.

Based on the initial positive study from MD Anderson on the genetic markers

our working hypothesis was that applying our Target-FISH method to lung cancer sputum samples could lead to a sensitive non-invasive test for early detection of lung cancer.

Initial Study:  Following the initial studies conducted at MD Anderson

we performed a study to validate our methodology.
In this study, we blindly tested 33 induced sputum samples: 15 patients with diagnosed lung cancer and 18 healthy non-smoking controls. Lung Cancer samples were analyzed for morphology and FISH alterations using the DUET system and the patented FISH probes prepared in house.
Each sample was analyzed using six different methods in order to compare their efficacy. We were able to show high sensitivity (in the range of 90%) in separating the lung cancer patients from the healthy controls.

Phase II Study:  In the second phase

we selected the most promising method of analysis and made several technical improvements to the FISH probes.
Using this improved approach, we analyzed 140 additional sputum samples.
The results were encouraging and exciting, since no reliable non-invasive test has yet been introduced to the scientific community.

Multi-Center Clinical Trial:  We then launched a multi-center Clinical Trial

to clinically validate our test that aims to aid the early detection of lung cancer in sputum on subjects having small (0.8-3cm) Solitary Pulmonary Nodules (SPN’s).

Results of our non-invasive FISH test were compared to the invasive biopsy results
The interim results show that the BioView LCD test has a sensitivity of >85%

a specificity of >74% and a Positive Predictive Value (PPV) of > 90%.
The results of the study were presented at several leading Congresses in 2015 and are being prepared for publication.
Present Status:  The LCD test got the CE Mark and is currently being marketed in China as a Laboratory Developed Test through a local Chinese partner.
In addition we are working on other regulatory approvals and seeking partners to commercialize the test in certain markets.
Shimoni, A., Nagler, A., Kaplinsky, C., Reichart, M., Avigdor, A ., Hardan, I ., Yeshurun, M., Daniely, M., Zilberstein, Y., Amariglio, N., Brok-Simoni, F., Rechavi, G., Trakhtenbrot, L.
(2002) Chimerism testing and detection of minimal residual disease after allogeneic hematopoiatic transplantation using BioView (DUET™) combined morphological and cytological analysis.
Leukemia 16, 1413-1418.
Hardan I., Rothman R., Gelibter A., Cohen N., Shomoni A., Sokolovsky M., Reichart M., Ishoev G., Amariglio, N.
, G.
Nagler A., Trakhtenbrot, L.
Determination of chromosome 13 in the bone marrow cells of patients with multiple myeloma using combined morphological and FISH analysis.
Experimental Hematology, 32, 254-260.
Slovak M.
L., Bedell V., Pagel K., Chang K.
L., Smith D., Somlo G (2005).
Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
Cancer genetic and cytogenetic158, 99-109.
Daniely M., Rona R., Kaplan T., Olsfanger S., Elboim L., Zilberstain Y., Friberger A., Kidron D., Kaplan E., Lew S., Leibovitch I.
Combined analysis of morphology and Fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples.
Urology 66, 1354-1359.
Barkan GE, Caraway NP, Jiang F, Zaidi TM, Fernandez R, Vaporcyin A, Morice R, Zhou X, Bekele BN, Katz RL (2005).

Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations

Cancer 105(1), 35-43.
Katz RL, Zaidi TM, Fernandez RL, Zhang J, He W, Acosta C, Daniely M, Madi L, Vargas MA, Dong Q, Gao X, Jiang F, Caraway NP, Vaporciyan AA, Roth JA, Spitz MR (2008) Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer; Mod Pathol; in press.
Barkan GA, Caraway NP, Jiang F, Zaidi TM, Fernandez R, Vaporcyin A, Morice R, Zhou X, Bekele BN, Katz RL (2004) Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations; Cancer Cytopathol; 105(1):35-43.

All Rights Reserved © bioview        design by


Board footer

Powered by FluxBB